Digitially created image of DNA

Identifying biomarkers in frontotemporal dementia

In order to develop treatments and effective interventions for patients with FTD, the underlying process of brain degeneration needs to be identified early in the disease course. FTD patients may have one of several different underlying brain pathologies which cannot at present be predicted by either the type of symptoms exhibited, or by a genetic profile. We are investigating protein changes in blood specimens that may tell us about the underlying brain pathology in FTD.